Back
Lyell Immunopharma Vs. Neurogene Industry Stock Comparison
Sell
23
LYEL
Lyell Immunopharma
Last Price:
1.10
Seasonality Move:
-22.41%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
23
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $1.10. The Score for LYEL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- LYEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $1.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYEL is experiencing slight buying pressure.
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.37 | Sell |
| Chaikin Money Flow: | 448885 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1 - 1.26) | Sell |
| Bollinger Bands (100): | (1.15 - 1.57) | Sell |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 35.74 | Sell |
| Chaikin Money Flow: | -452975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.4 - 61.5) | Sell |
| Bollinger Bands (100): | (34.32 - 50.52) | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.2 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.21 | Sell |
| 200-day SMA: | 1.85 | Sell |
| 8-day EMA: | 1.14 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.71 | Sell |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Sell |
| 20-day SMA: | 51.47 | Sell |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 38.99 | Sell |
| 8-day EMA: | 47.13 | Sell |
| 20-day EMA: | 50.2 | Sell |
| 50-day EMA: | 47.47 | Sell |
| 200-day EMA: | 38.44 | Sell |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Lyell Immunopharma Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||